![Biology | Free Full-Text | Bright Light Therapy for Parkinson Disease: A Literature Review and Meta-Analysis of Randomized Controlled Trials | HTML Biology | Free Full-Text | Bright Light Therapy for Parkinson Disease: A Literature Review and Meta-Analysis of Randomized Controlled Trials | HTML](https://www.mdpi.com/biology/biology-10-01205/article_deploy/html/images/biology-10-01205-g001.png)
Biology | Free Full-Text | Bright Light Therapy for Parkinson Disease: A Literature Review and Meta-Analysis of Randomized Controlled Trials | HTML
![Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care - Cytotherapy Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care - Cytotherapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/03166251-961d-4233-918b-6dee486ef04f/gr1.jpg)
Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care - Cytotherapy
![An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding - Journal of Pediatric and Adolescent Gynecology An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding - Journal of Pediatric and Adolescent Gynecology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a26dc366-c187-428b-864d-c76eb36ea122/gr1_lrg.jpg)
An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding - Journal of Pediatric and Adolescent Gynecology
![PDF] An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. | Semantic Scholar PDF] An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bd292c301c51a1f717d8f0c14788762c69120a87/4-Figure1-1.png)
PDF] An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. | Semantic Scholar
![CONSORT flow diagram. Patient allocation in single-arm open label pilot... | Download Scientific Diagram CONSORT flow diagram. Patient allocation in single-arm open label pilot... | Download Scientific Diagram](https://www.researchgate.net/publication/330167180/figure/fig2/AS:817604323188737@1571943469269/CONSORT-flow-diagram-Patient-allocation-in-single-arm-open-label-pilot-study-conducted.png)
CONSORT flow diagram. Patient allocation in single-arm open label pilot... | Download Scientific Diagram
![Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open- label, single-arm, phase 2 trial - Radiotherapy and Oncology Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open- label, single-arm, phase 2 trial - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/72b348e1-6a5e-4ac0-832d-a297172d7720/gr1_lrg.jpg)
Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open- label, single-arm, phase 2 trial - Radiotherapy and Oncology
![Effect of Facial Cosmetic Acupuncture on Facial Elasticity: An Open-Label, Single-Arm Pilot Study – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open Effect of Facial Cosmetic Acupuncture on Facial Elasticity: An Open-Label, Single-Arm Pilot Study – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open](https://cyberleninka.org/viewer_images/269410/f/1.png)
Effect of Facial Cosmetic Acupuncture on Facial Elasticity: An Open-Label, Single-Arm Pilot Study – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
![Hanan Goldberg on Twitter: "Dr. De Wit presenting Keynote 057 study results, a single arm open label study of pembrolizumab in NMIBC patients unresponsive to BCG, demonstrating complete response rates of 38.8%! Hanan Goldberg on Twitter: "Dr. De Wit presenting Keynote 057 study results, a single arm open label study of pembrolizumab in NMIBC patients unresponsive to BCG, demonstrating complete response rates of 38.8%!](https://pbs.twimg.com/media/Dp8RsplXgAAYsBF.jpg)
Hanan Goldberg on Twitter: "Dr. De Wit presenting Keynote 057 study results, a single arm open label study of pembrolizumab in NMIBC patients unresponsive to BCG, demonstrating complete response rates of 38.8%!
PLOS ONE: A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
![An open label, single arm, prospective clinical study to evaluate liver safety and tolerability of PUREMERIC™ (standardized extract from Curcuma longa) in healthy subjects - ScienceDirect An open label, single arm, prospective clinical study to evaluate liver safety and tolerability of PUREMERIC™ (standardized extract from Curcuma longa) in healthy subjects - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2214750021002067-ga1.jpg)
An open label, single arm, prospective clinical study to evaluate liver safety and tolerability of PUREMERIC™ (standardized extract from Curcuma longa) in healthy subjects - ScienceDirect
![Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC—a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier ... Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC—a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/28cc28ce-6ec1-45d7-8715-631eafb086e0/gr1.jpg)
Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC—a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier ...
![Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study - The Lancet Haematology Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study - The Lancet Haematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2099072967/2079004706/gr1.gif)
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study - The Lancet Haematology
PLOS ONE: Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)—An open-label, single-arm study
![A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters - Journal of Vascular and Interventional Radiology A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters - Journal of Vascular and Interventional Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2002785167/2010095522/gr1.jpg)
A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters - Journal of Vascular and Interventional Radiology
![Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial - Clark - 2020 - Health Science Reports - Wiley Online Library Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial - Clark - 2020 - Health Science Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/17ffd76c-258c-4d8d-9371-16ed1d2b198f/hsr2.154.fp.png)
Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial - Clark - 2020 - Health Science Reports - Wiley Online Library
![PDF] A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis | Semantic Scholar PDF] A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ff8c21a61028240726f6a4d4b51edb39ea052f1c/3-Figure1-1.png)
PDF] A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis | Semantic Scholar
![Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study - European Journal of Cancer Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f3751290-e9b8-4786-ae33-dcbf818f83c6/gr1.jpg)
Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study - European Journal of Cancer
![CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... | Download Scientific Diagram CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... | Download Scientific Diagram](https://www.researchgate.net/profile/Stina-Wichert/publication/313332310/figure/fig1/AS:458060259958784@1486221484711/CONSORT-flowchart-for-A-single-arm-open-label-phase-2-clinical-trial-with-BI-505-a.png)
CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... | Download Scientific Diagram
The study was design as single-arm open-label trial consisting of a 14... | Download Scientific Diagram
![An Open-label, Single-arm Study of CRYO2 for Debulking at the Site of Central Airway Obstruction or Stenosis | In Vivo An Open-label, Single-arm Study of CRYO2 for Debulking at the Site of Central Airway Obstruction or Stenosis | In Vivo](https://iv.iiarjournals.org/content/invivo/33/5/1641/F1.large.jpg)
An Open-label, Single-arm Study of CRYO2 for Debulking at the Site of Central Airway Obstruction or Stenosis | In Vivo
![Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment - Respiratory Medicine Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c1efbb09-890b-4c45-a369-e82065ae2d31/gr1_lrg.jpg)